Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/12/2025
Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...
6/12/2025
Viatris Wins NMPA Approval for Once‑Daily Nebulized COPD Therapy Yupe...
6/10/2025
Gavi Launches $224M Arbitration Claim Against Clover Biopharma Over CO...
6/9/2025
Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted
6/6/2025
AbbVie's Rinvoq (Upadacitinib) Gains Approval in China for Giant Cell ...
6/4/2025
China Approves First Homegrown 9-Valent HPV Vaccine
6/3/2025
Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval
5/31/2025
Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...
5/31/2025
Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...
5/31/2025
China Approves First Homegrown Nine-Valent HPV Vaccine
5/29/2025
Novartis Secures NMPA Approval for Beovu for DME in China
5/29/2025
China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer
5/29/2025
China Approves Zelgen's Gecacitinib
5/29/2025
China Grants Conditional Approval to Hengrui's Famitinib
5/29/2025
CDE Solicits Comments on Draft Technical Considerations for NMR Studi...
5/27/2025
RemeGen's Telitacicept Gains Approval in China
5/22/2025
NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...
5/21/2025
China's Drugstores Decline Amid Boom in Online Healthcare
5/16/2025
CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...
5/16/2025
China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...
5/15/2025
Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...
4/29/2025
Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial
4/25/2025
Akeso's Ivonescimab Gains Second Approval in China
4/24/2025
Merck's Gardasil Sales Plunge Amid China Market Turbulence
4/24/2025
Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...
4/23/2025
China Accelerates Development of Multivalent Vaccines and Digital Immu...
4/23/2025
Cheaper Chinese HPV Vaccines Turn Merck's Gardasil From Boom to Bust (...
4/15/2025
Gardasil9 Gains Expanded Approval in China
4/14/2025
China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...
4/9/2025
China Launches Phase I Trial for Nation's First Monkeypox Vaccine
Page:
1
/
72
Total number of articles:
2153
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit